nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—CYP3A4—bone cancer	0.16	0.505	CbGaD
Dexamethasone—PTGS2—bone cancer	0.157	0.495	CbGaD
Dexamethasone—NOS2—Doxorubicin—bone cancer	0.113	0.229	CbGbCtD
Dexamethasone—CYP4A11—Cisplatin—bone cancer	0.0965	0.196	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—bone cancer	0.0268	0.0545	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—bone cancer	0.0268	0.0545	CbGbCtD
Dexamethasone—ABCC2—Carboplatin—bone cancer	0.0246	0.0501	CbGbCtD
Dexamethasone—ABCG2—Carboplatin—bone cancer	0.0223	0.0453	CbGbCtD
Dexamethasone—ABCC2—Cisplatin—bone cancer	0.0211	0.0428	CbGbCtD
Dexamethasone—PTGS2—Cisplatin—bone cancer	0.0208	0.0423	CbGbCtD
Dexamethasone—ABCG2—Cisplatin—bone cancer	0.019	0.0387	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—bone cancer	0.0165	0.0335	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—bone cancer	0.0141	0.0287	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—bone cancer	0.0137	0.0278	CbGbCtD
Dexamethasone—CYP2B6—Cisplatin—bone cancer	0.0134	0.0272	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—bone cancer	0.0128	0.0259	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—bone cancer	0.0124	0.0251	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—bone cancer	0.00897	0.0182	CbGbCtD
Dexamethasone—CYP2C9—Cisplatin—bone cancer	0.00707	0.0144	CbGbCtD
Dexamethasone—ABCB1—Cisplatin—bone cancer	0.00687	0.0139	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—bone cancer	0.0046	0.00935	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—bone cancer	0.00446	0.00906	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—bone cancer	0.00433	0.00881	CbGbCtD
Dexamethasone—CYP3A4—Doxorubicin—bone cancer	0.00276	0.0056	CbGbCtD
Dexamethasone—Fluocinonide—SMO—bone cancer	0.00157	0.417	CrCbGaD
Dexamethasone—Dermatitis contact—Epirubicin—bone cancer	0.000228	0.00251	CcSEcCtD
Dexamethasone—Ulcer—Doxorubicin—bone cancer	0.000226	0.00248	CcSEcCtD
Dexamethasone—Ecchymosis—Methotrexate—bone cancer	0.000223	0.00245	CcSEcCtD
Dexamethasone—Skin exfoliation—Epirubicin—bone cancer	0.00022	0.00242	CcSEcCtD
Dexamethasone—Pulmonary oedema—Methotrexate—bone cancer	0.00022	0.00242	CcSEcCtD
Dexamethasone—Fluid retention—Epirubicin—bone cancer	0.000219	0.00241	CcSEcCtD
Dexamethasone—Visual impairment—Cisplatin—bone cancer	0.000218	0.00239	CcSEcCtD
Dexamethasone—Neuropathy—Epirubicin—bone cancer	0.000217	0.00238	CcSEcCtD
Dexamethasone—Hiccups—Doxorubicin—bone cancer	0.000214	0.00235	CcSEcCtD
Dexamethasone—Dry eye—Epirubicin—bone cancer	0.000213	0.00235	CcSEcCtD
Dexamethasone—Dermatitis contact—Doxorubicin—bone cancer	0.000211	0.00232	CcSEcCtD
Dexamethasone—Eye disorder—Cisplatin—bone cancer	0.000211	0.00232	CcSEcCtD
Dexamethasone—Oesophagitis—Epirubicin—bone cancer	0.000211	0.00232	CcSEcCtD
Dexamethasone—Ecchymosis—Epirubicin—bone cancer	0.000209	0.0023	CcSEcCtD
Dexamethasone—Thrombophlebitis—Methotrexate—bone cancer	0.000207	0.00228	CcSEcCtD
Dexamethasone—Budesonide—CYP3A4—bone cancer	0.000207	0.0548	CrCbGaD
Dexamethasone—Diabetes mellitus—Methotrexate—bone cancer	0.000206	0.00226	CcSEcCtD
Dexamethasone—Pulmonary oedema—Epirubicin—bone cancer	0.000206	0.00226	CcSEcCtD
Dexamethasone—Skin exfoliation—Doxorubicin—bone cancer	0.000204	0.00224	CcSEcCtD
Dexamethasone—Fluid retention—Doxorubicin—bone cancer	0.000203	0.00223	CcSEcCtD
Dexamethasone—Fluticasone furoate—CYP3A4—bone cancer	0.000203	0.0538	CrCbGaD
Dexamethasone—Arrhythmia—Cisplatin—bone cancer	0.000202	0.00222	CcSEcCtD
Dexamethasone—Neuropathy—Doxorubicin—bone cancer	0.000201	0.00221	CcSEcCtD
Dexamethasone—Alopecia—Cisplatin—bone cancer	0.0002	0.00219	CcSEcCtD
Dexamethasone—Dry eye—Doxorubicin—bone cancer	0.000197	0.00217	CcSEcCtD
Dexamethasone—Erythema—Cisplatin—bone cancer	0.000197	0.00216	CcSEcCtD
Dexamethasone—Oesophagitis—Doxorubicin—bone cancer	0.000195	0.00215	CcSEcCtD
Dexamethasone—Thrombophlebitis—Epirubicin—bone cancer	0.000194	0.00213	CcSEcCtD
Dexamethasone—Ecchymosis—Doxorubicin—bone cancer	0.000193	0.00212	CcSEcCtD
Dexamethasone—Diabetes mellitus—Epirubicin—bone cancer	0.000193	0.00212	CcSEcCtD
Dexamethasone—Pulmonary oedema—Doxorubicin—bone cancer	0.00019	0.00209	CcSEcCtD
Dexamethasone—Visual disturbance—Methotrexate—bone cancer	0.000189	0.00208	CcSEcCtD
Dexamethasone—Eye pain—Epirubicin—bone cancer	0.000186	0.00204	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Methotrexate—bone cancer	0.000185	0.00204	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Epirubicin—bone cancer	0.000185	0.00203	CcSEcCtD
Dexamethasone—Lethargy—Methotrexate—bone cancer	0.000183	0.00201	CcSEcCtD
Dexamethasone—Ill-defined disorder—Cisplatin—bone cancer	0.000182	0.00201	CcSEcCtD
Dexamethasone—Thrombophlebitis—Doxorubicin—bone cancer	0.000179	0.00197	CcSEcCtD
Dexamethasone—Osteoarthritis—Methotrexate—bone cancer	0.000179	0.00197	CcSEcCtD
Dexamethasone—Increased appetite—Epirubicin—bone cancer	0.000178	0.00196	CcSEcCtD
Dexamethasone—Diabetes mellitus—Doxorubicin—bone cancer	0.000178	0.00196	CcSEcCtD
Dexamethasone—Alclometasone—CYP3A4—bone cancer	0.000178	0.0473	CrCbGaD
Dexamethasone—Malaise—Cisplatin—bone cancer	0.000177	0.00195	CcSEcCtD
Dexamethasone—Dermatitis bullous—Epirubicin—bone cancer	0.000175	0.00193	CcSEcCtD
Dexamethasone—Flunisolide—CYP3A4—bone cancer	0.000173	0.046	CrCbGaD
Dexamethasone—Anaphylactoid reaction—Epirubicin—bone cancer	0.000173	0.0019	CcSEcCtD
Dexamethasone—Eye pain—Doxorubicin—bone cancer	0.000172	0.00189	CcSEcCtD
Dexamethasone—Cardiac failure—Epirubicin—bone cancer	0.000172	0.00189	CcSEcCtD
Dexamethasone—Paramethasone—CYP3A4—bone cancer	0.000171	0.0454	CrCbGaD
Dexamethasone—Lethargy—Epirubicin—bone cancer	0.000171	0.00188	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Doxorubicin—bone cancer	0.000171	0.00188	CcSEcCtD
Dexamethasone—Irritability—Methotrexate—bone cancer	0.000171	0.00188	CcSEcCtD
Dexamethasone—Convulsion—Cisplatin—bone cancer	0.00017	0.00187	CcSEcCtD
Dexamethasone—Mood swings—Methotrexate—bone cancer	0.00017	0.00187	CcSEcCtD
Dexamethasone—Osteoarthritis—Epirubicin—bone cancer	0.000168	0.00184	CcSEcCtD
Dexamethasone—Myalgia—Cisplatin—bone cancer	0.000167	0.00184	CcSEcCtD
Dexamethasone—Fluorometholone—CYP3A4—bone cancer	0.000167	0.0444	CrCbGaD
Dexamethasone—Anxiety—Cisplatin—bone cancer	0.000167	0.00183	CcSEcCtD
Dexamethasone—Discomfort—Cisplatin—bone cancer	0.000165	0.00182	CcSEcCtD
Dexamethasone—Increased appetite—Doxorubicin—bone cancer	0.000165	0.00182	CcSEcCtD
Dexamethasone—Affect lability—Epirubicin—bone cancer	0.000165	0.00181	CcSEcCtD
Dexamethasone—Migraine—Epirubicin—bone cancer	0.000165	0.00181	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—bone cancer	0.000162	0.00178	CcSEcCtD
Dexamethasone—Methylprednisolone—CYP3A4—bone cancer	0.000162	0.0429	CrCbGaD
Dexamethasone—Anaphylactic shock—Cisplatin—bone cancer	0.00016	0.00176	CcSEcCtD
Dexamethasone—Oedema—Cisplatin—bone cancer	0.00016	0.00176	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00016	0.00176	CcSEcCtD
Dexamethasone—Cardiac arrest—Epirubicin—bone cancer	0.000159	0.00175	CcSEcCtD
Dexamethasone—Infection—Cisplatin—bone cancer	0.000159	0.00175	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—bone cancer	0.000159	0.00175	CcSEcCtD
Dexamethasone—Mood swings—Epirubicin—bone cancer	0.000159	0.00175	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—bone cancer	0.000158	0.00174	CcSEcCtD
Dexamethasone—Nervous system disorder—Cisplatin—bone cancer	0.000157	0.00173	CcSEcCtD
Dexamethasone—Thrombocytopenia—Cisplatin—bone cancer	0.000157	0.00173	CcSEcCtD
Dexamethasone—Tachycardia—Cisplatin—bone cancer	0.000157	0.00172	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—bone cancer	0.000155	0.00171	CcSEcCtD
Dexamethasone—Hyperhidrosis—Cisplatin—bone cancer	0.000155	0.00171	CcSEcCtD
Dexamethasone—Dry skin—Epirubicin—bone cancer	0.000154	0.00169	CcSEcCtD
Dexamethasone—Anorexia—Cisplatin—bone cancer	0.000153	0.00168	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—bone cancer	0.000153	0.00168	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—bone cancer	0.000153	0.00168	CcSEcCtD
Dexamethasone—Hypokalaemia—Epirubicin—bone cancer	0.000153	0.00168	CcSEcCtD
Dexamethasone—Hypotension—Cisplatin—bone cancer	0.00015	0.00165	CcSEcCtD
Dexamethasone—Muscular weakness—Epirubicin—bone cancer	0.000148	0.00163	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—bone cancer	0.000147	0.00162	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—bone cancer	0.000147	0.00162	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000146	0.00161	CcSEcCtD
Dexamethasone—Paraesthesia—Cisplatin—bone cancer	0.000144	0.00158	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—bone cancer	0.000142	0.00156	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—bone cancer	0.000141	0.00155	CcSEcCtD
Dexamethasone—Decreased appetite—Cisplatin—bone cancer	0.000139	0.00153	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000138	0.00152	CcSEcCtD
Dexamethasone—Pain—Cisplatin—bone cancer	0.000137	0.00151	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—bone cancer	0.000137	0.0015	CcSEcCtD
Dexamethasone—Triamcinolone—CYP3A4—bone cancer	0.000136	0.0362	CrCbGaD
Dexamethasone—Conjunctivitis—Methotrexate—bone cancer	0.000134	0.00148	CcSEcCtD
Dexamethasone—Triamcinolone—PTGS2—bone cancer	0.000133	0.0354	CrCbGaD
Dexamethasone—Feeling abnormal—Cisplatin—bone cancer	0.000132	0.00145	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—bone cancer	0.000132	0.00145	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—bone cancer	0.000131	0.00144	CcSEcCtD
Dexamethasone—Hyperglycaemia—Epirubicin—bone cancer	0.000131	0.00144	CcSEcCtD
Dexamethasone—Body temperature increased—Cisplatin—bone cancer	0.000127	0.00139	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—bone cancer	0.000127	0.00139	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—bone cancer	0.000126	0.00138	CcSEcCtD
Dexamethasone—Haemoglobin—Methotrexate—bone cancer	0.000125	0.00137	CcSEcCtD
Dexamethasone—Haemorrhage—Methotrexate—bone cancer	0.000124	0.00136	CcSEcCtD
Dexamethasone—Prednisone—CYP3A4—bone cancer	0.000124	0.0328	CrCbGaD
Dexamethasone—Weight increased—Doxorubicin—bone cancer	0.000122	0.00134	CcSEcCtD
Dexamethasone—Fluticasone Propionate—CYP3A4—bone cancer	0.000122	0.0323	CrCbGaD
Dexamethasone—Weight decreased—Doxorubicin—bone cancer	0.000121	0.00133	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—bone cancer	0.000121	0.00133	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—bone cancer	0.000119	0.00131	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—bone cancer	0.000118	0.0013	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000117	0.00129	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—bone cancer	0.000117	0.00128	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—bone cancer	0.000116	0.00128	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—bone cancer	0.000116	0.00128	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—bone cancer	0.000116	0.00127	CcSEcCtD
Dexamethasone—Asthenia—Cisplatin—bone cancer	0.000115	0.00127	CcSEcCtD
Dexamethasone—Prednisolone—CYP3A4—bone cancer	0.000114	0.0302	CrCbGaD
Dexamethasone—Angiopathy—Methotrexate—bone cancer	0.000112	0.00124	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—bone cancer	0.000112	0.00123	CcSEcCtD
Dexamethasone—Betamethasone—CYP3A4—bone cancer	0.000112	0.0296	CrCbGaD
Dexamethasone—Diarrhoea—Cisplatin—bone cancer	0.00011	0.00121	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—bone cancer	0.000109	0.0012	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—bone cancer	0.000109	0.0012	CcSEcCtD
Dexamethasone—Betamethasone—PTGS2—bone cancer	0.000109	0.029	CrCbGaD
Dexamethasone—Eye disorder—Epirubicin—bone cancer	0.000108	0.00119	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—bone cancer	0.000108	0.00119	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—bone cancer	0.000108	0.00119	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—bone cancer	0.000107	0.00118	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—bone cancer	0.000105	0.00116	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—bone cancer	0.000104	0.00114	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—bone cancer	0.000103	0.00114	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—bone cancer	0.000102	0.00113	CcSEcCtD
Dexamethasone—Vomiting—Cisplatin—bone cancer	0.000102	0.00112	CcSEcCtD
Dexamethasone—Rash—Cisplatin—bone cancer	0.000101	0.00111	CcSEcCtD
Dexamethasone—Dermatitis—Cisplatin—bone cancer	0.000101	0.00111	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—bone cancer	0.000101	0.00111	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—bone cancer	0.0001	0.0011	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—bone cancer	0.0001	0.0011	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—bone cancer	9.73e-05	0.00107	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—bone cancer	9.73e-05	0.00107	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—bone cancer	9.69e-05	0.00107	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—bone cancer	9.58e-05	0.00105	CcSEcCtD
Dexamethasone—Nausea—Cisplatin—bone cancer	9.53e-05	0.00105	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—bone cancer	9.48e-05	0.00104	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—bone cancer	9.37e-05	0.00103	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—bone cancer	9.35e-05	0.00103	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—bone cancer	9.34e-05	0.00103	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—bone cancer	9.18e-05	0.00101	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—bone cancer	9.1e-05	0.001	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—bone cancer	9.07e-05	0.000998	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—bone cancer	9.07e-05	0.000998	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—bone cancer	9.05e-05	0.000996	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—bone cancer	8.87e-05	0.000976	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—bone cancer	8.8e-05	0.000968	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—bone cancer	8.75e-05	0.000962	CcSEcCtD
Dexamethasone—Infection—Methotrexate—bone cancer	8.75e-05	0.000962	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—bone cancer	8.71e-05	0.000959	CcSEcCtD
Dexamethasone—Hydrocortisone—CYP3A4—bone cancer	8.71e-05	0.0231	CrCbGaD
Dexamethasone—Ill-defined disorder—Doxorubicin—bone cancer	8.67e-05	0.000953	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—bone cancer	8.63e-05	0.00095	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—bone cancer	8.62e-05	0.000948	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—bone cancer	8.59e-05	0.000945	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—bone cancer	8.56e-05	0.000942	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—bone cancer	8.51e-05	0.000936	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—bone cancer	8.49e-05	0.000934	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—bone cancer	8.42e-05	0.000926	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—bone cancer	8.39e-05	0.000923	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—bone cancer	8.39e-05	0.000923	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—bone cancer	8.38e-05	0.000921	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—bone cancer	8.24e-05	0.000906	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—bone cancer	8.24e-05	0.000906	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—bone cancer	8.23e-05	0.000905	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—bone cancer	8.21e-05	0.000903	CcSEcCtD
Dexamethasone—Infection—Epirubicin—bone cancer	8.18e-05	0.0009	CcSEcCtD
Dexamethasone—Shock—Epirubicin—bone cancer	8.11e-05	0.000891	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—bone cancer	8.09e-05	0.00089	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—bone cancer	8.08e-05	0.000889	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—bone cancer	8.07e-05	0.000887	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—bone cancer	8.06e-05	0.000887	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—bone cancer	8.04e-05	0.000884	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—bone cancer	8.02e-05	0.000882	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—bone cancer	7.96e-05	0.000876	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—bone cancer	7.96e-05	0.000876	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—bone cancer	7.95e-05	0.000875	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—bone cancer	7.92e-05	0.000872	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—bone cancer	7.9e-05	0.000869	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—bone cancer	7.86e-05	0.000864	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—bone cancer	7.85e-05	0.000864	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—bone cancer	7.75e-05	0.000852	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—bone cancer	7.7e-05	0.000847	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—bone cancer	7.65e-05	0.000842	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—bone cancer	7.62e-05	0.000838	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—bone cancer	7.62e-05	0.000838	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—bone cancer	7.6e-05	0.000836	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—bone cancer	7.59e-05	0.000835	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—bone cancer	7.57e-05	0.000833	CcSEcCtD
Dexamethasone—Pain—Methotrexate—bone cancer	7.53e-05	0.000828	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—bone cancer	7.51e-05	0.000826	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—bone cancer	7.5e-05	0.000825	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—bone cancer	7.48e-05	0.000822	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—bone cancer	7.46e-05	0.000821	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—bone cancer	7.45e-05	0.00082	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—bone cancer	7.44e-05	0.000818	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—bone cancer	7.4e-05	0.000814	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—bone cancer	7.37e-05	0.000811	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—bone cancer	7.27e-05	0.000799	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—bone cancer	7.25e-05	0.000798	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—bone cancer	7.25e-05	0.000798	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—bone cancer	7.2e-05	0.000792	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—bone cancer	7.16e-05	0.000788	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—bone cancer	7.12e-05	0.000783	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—bone cancer	7.11e-05	0.000782	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—bone cancer	7.1e-05	0.000781	CcSEcCtD
Dexamethasone—Pain—Epirubicin—bone cancer	7.04e-05	0.000775	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—bone cancer	6.99e-05	0.000769	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—bone cancer	6.96e-05	0.000765	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—bone cancer	6.96e-05	0.000765	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—bone cancer	6.94e-05	0.000764	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—bone cancer	6.89e-05	0.000758	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—bone cancer	6.84e-05	0.000753	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—bone cancer	6.79e-05	0.000747	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—bone cancer	6.74e-05	0.000741	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—bone cancer	6.71e-05	0.000738	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—bone cancer	6.63e-05	0.000729	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—bone cancer	6.58e-05	0.000724	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—bone cancer	6.57e-05	0.000723	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—bone cancer	6.54e-05	0.00072	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—bone cancer	6.52e-05	0.000717	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—bone cancer	6.51e-05	0.000716	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—bone cancer	6.51e-05	0.000716	CcSEcCtD
Dexamethasone—Asthenia—Methotrexate—bone cancer	6.32e-05	0.000695	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—bone cancer	6.28e-05	0.000691	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—bone cancer	6.23e-05	0.000686	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—bone cancer	6.23e-05	0.000685	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—bone cancer	6.06e-05	0.000666	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—bone cancer	6.03e-05	0.000663	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—bone cancer	6.03e-05	0.000663	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—bone cancer	6.02e-05	0.000662	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—bone cancer	5.91e-05	0.00065	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—bone cancer	5.83e-05	0.000641	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—bone cancer	5.82e-05	0.00064	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—bone cancer	5.64e-05	0.00062	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—bone cancer	5.6e-05	0.000616	CcSEcCtD
Dexamethasone—Rash—Methotrexate—bone cancer	5.55e-05	0.000611	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—bone cancer	5.55e-05	0.00061	CcSEcCtD
Dexamethasone—Headache—Methotrexate—bone cancer	5.51e-05	0.000607	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—bone cancer	5.47e-05	0.000602	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—bone cancer	5.45e-05	0.000599	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—bone cancer	5.39e-05	0.000593	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—bone cancer	5.24e-05	0.000576	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—bone cancer	5.23e-05	0.000575	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—bone cancer	5.22e-05	0.000574	CcSEcCtD
Dexamethasone—Rash—Epirubicin—bone cancer	5.19e-05	0.000571	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—bone cancer	5.19e-05	0.000571	CcSEcCtD
Dexamethasone—Headache—Epirubicin—bone cancer	5.16e-05	0.000568	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—bone cancer	5.04e-05	0.000554	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—bone cancer	4.89e-05	0.000538	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—bone cancer	4.85e-05	0.000533	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—bone cancer	4.81e-05	0.000529	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—bone cancer	4.8e-05	0.000528	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—bone cancer	4.78e-05	0.000525	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—bone cancer	4.53e-05	0.000498	CcSEcCtD
Dexamethasone—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	3.23e-05	0.000336	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—GNA11—bone cancer	3.23e-05	0.000336	CbGpPWpGaD
Dexamethasone—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	3.2e-05	0.000333	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	3.2e-05	0.000332	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—DHFR—bone cancer	3.19e-05	0.000332	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—NT5C3A—bone cancer	3.19e-05	0.000332	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—NT5C3A—bone cancer	3.16e-05	0.000329	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GRM4—bone cancer	3.16e-05	0.000328	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RGS1—bone cancer	3.16e-05	0.000328	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	3.15e-05	0.000328	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—EIF2S1—bone cancer	3.11e-05	0.000323	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	3.09e-05	0.000321	CbGpPWpGaD
Dexamethasone—CYP2C19—Biological oxidations—GSTP1—bone cancer	3.04e-05	0.000316	CbGpPWpGaD
Dexamethasone—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	3e-05	0.000312	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ATF1—bone cancer	3e-05	0.000312	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	2.99e-05	0.00031	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—GNA11—bone cancer	2.98e-05	0.00031	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NDUFA12—bone cancer	2.94e-05	0.000305	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—GSTP1—bone cancer	2.94e-05	0.000305	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL3—bone cancer	2.93e-05	0.000304	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—NT5C3A—bone cancer	2.9e-05	0.000301	CbGpPWpGaD
Dexamethasone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	2.83e-05	0.000294	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NDUFA12—bone cancer	2.82e-05	0.000294	CbGpPWpGaD
Dexamethasone—CYP2D6—Biological oxidations—GSTP1—bone cancer	2.8e-05	0.000291	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.79e-05	0.00029	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	2.79e-05	0.00029	CbGpPWpGaD
Dexamethasone—CYP2C9—Biological oxidations—GSTP1—bone cancer	2.78e-05	0.000289	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NDUFA12—bone cancer	2.77e-05	0.000287	CbGpPWpGaD
Dexamethasone—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	2.76e-05	0.000287	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NDUFA12—bone cancer	2.76e-05	0.000287	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GRM1—bone cancer	2.74e-05	0.000285	CbGpPWpGaD
Dexamethasone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	2.74e-05	0.000285	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CYP3A4—bone cancer	2.7e-05	0.000281	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—EZH2—bone cancer	2.7e-05	0.000281	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TGFBR2—bone cancer	2.7e-05	0.00028	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	2.67e-05	0.000278	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.66e-05	0.000277	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ENO2—bone cancer	2.63e-05	0.000274	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NDUFA12—bone cancer	2.61e-05	0.000271	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—MMP9—bone cancer	2.58e-05	0.000268	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	2.56e-05	0.000266	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TGFBR2—bone cancer	2.5e-05	0.00026	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—DHFR—bone cancer	2.44e-05	0.000254	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—NR1I2—bone cancer	2.43e-05	0.000253	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NT5C3A—bone cancer	2.43e-05	0.000253	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ENO2—bone cancer	2.41e-05	0.00025	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NDUFA12—bone cancer	2.39e-05	0.000248	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ENO2—bone cancer	2.38e-05	0.000248	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IGF1R—bone cancer	2.35e-05	0.000245	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NT5C3A—bone cancer	2.34e-05	0.000243	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—GSTP1—bone cancer	2.31e-05	0.00024	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.3e-05	0.000239	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NT5C3A—bone cancer	2.29e-05	0.000238	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NT5C3A—bone cancer	2.29e-05	0.000238	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—GNA11—bone cancer	2.28e-05	0.000237	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—DHFR—bone cancer	2.24e-05	0.000232	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—DHFR—bone cancer	2.21e-05	0.00023	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NT5C3A—bone cancer	2.16e-05	0.000225	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	2.15e-05	0.000223	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NDUFA12—bone cancer	2.13e-05	0.000222	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ENO2—bone cancer	2.12e-05	0.00022	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—GNA11—bone cancer	2.09e-05	0.000217	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NDUFA12—bone cancer	2.08e-05	0.000216	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—EGFR—bone cancer	2.08e-05	0.000216	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.07e-05	0.000215	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CYP3A4—bone cancer	2.07e-05	0.000215	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—GNA11—bone cancer	2.07e-05	0.000215	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.06e-05	0.000214	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.98e-05	0.000206	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NT5C3A—bone cancer	1.98e-05	0.000206	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NDUFA12—bone cancer	1.96e-05	0.000204	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—DHFR—bone cancer	1.96e-05	0.000204	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NDUFA12—bone cancer	1.95e-05	0.000202	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SMO—bone cancer	1.93e-05	0.000201	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CYP3A4—bone cancer	1.89e-05	0.000197	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.88e-05	0.000196	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CYP3A4—bone cancer	1.87e-05	0.000195	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.87e-05	0.000194	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KIT—bone cancer	1.84e-05	0.000191	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GNA11—bone cancer	1.83e-05	0.000191	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.83e-05	0.00019	CbGpPWpGaD
Dexamethasone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.81e-05	0.000188	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.8e-05	0.000187	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—EIF2S1—bone cancer	1.8e-05	0.000187	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—GSTP1—bone cancer	1.77e-05	0.000184	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NT5C3A—bone cancer	1.77e-05	0.000184	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ENO2—bone cancer	1.77e-05	0.000184	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GNA11—bone cancer	1.76e-05	0.000183	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—bone cancer	1.75e-05	0.000182	CbGpPWpGaD
Dexamethasone—NOS2—Disease—BRAF—bone cancer	1.73e-05	0.00018	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NT5C3A—bone cancer	1.73e-05	0.000179	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—bone cancer	1.72e-05	0.000178	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KIT—bone cancer	1.71e-05	0.000178	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CYP3A4—bone cancer	1.66e-05	0.000173	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.65e-05	0.000172	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ATF1—bone cancer	1.64e-05	0.000171	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—DHFR—bone cancer	1.64e-05	0.00017	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NT5C3A—bone cancer	1.63e-05	0.000169	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—GSTP1—bone cancer	1.62e-05	0.000168	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NT5C3A—bone cancer	1.61e-05	0.000168	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—BRAF—bone cancer	1.61e-05	0.000167	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—GSTP1—bone cancer	1.6e-05	0.000167	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL3—bone cancer	1.6e-05	0.000166	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ENO2—bone cancer	1.6e-05	0.000166	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—EZH2—bone cancer	1.56e-05	0.000162	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—EGFR—bone cancer	1.56e-05	0.000162	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ENO2—bone cancer	1.54e-05	0.00016	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GNA11—bone cancer	1.53e-05	0.000159	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PTGS2—bone cancer	1.52e-05	0.000158	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—DHFR—bone cancer	1.48e-05	0.000154	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.47e-05	0.000153	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MDM2—bone cancer	1.45e-05	0.000151	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—DHFR—bone cancer	1.43e-05	0.000148	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GSTP1—bone cancer	1.42e-05	0.000148	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.42e-05	0.000147	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.42e-05	0.000147	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ENO2—bone cancer	1.4e-05	0.000145	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTGS2—bone cancer	1.4e-05	0.000145	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CYP3A4—bone cancer	1.39e-05	0.000144	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ENO2—bone cancer	1.39e-05	0.000144	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GNA11—bone cancer	1.38e-05	0.000144	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.38e-05	0.000144	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFBR2—bone cancer	1.37e-05	0.000142	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MDM2—bone cancer	1.35e-05	0.00014	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GNA11—bone cancer	1.33e-05	0.000139	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—DHFR—bone cancer	1.3e-05	0.000135	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IGF1R—bone cancer	1.29e-05	0.000134	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—DHFR—bone cancer	1.29e-05	0.000134	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NDUFA12—bone cancer	1.28e-05	0.000133	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.28e-05	0.000133	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ENO2—bone cancer	1.27e-05	0.000132	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ENO2—bone cancer	1.27e-05	0.000132	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CYP3A4—bone cancer	1.25e-05	0.00013	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.25e-05	0.00013	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GNA11—bone cancer	1.21e-05	0.000126	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CYP3A4—bone cancer	1.21e-05	0.000126	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.2e-05	0.000125	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GNA11—bone cancer	1.2e-05	0.000125	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PTGS2—bone cancer	1.2e-05	0.000125	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.19e-05	0.000124	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GSTP1—bone cancer	1.19e-05	0.000123	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—DHFR—bone cancer	1.18e-05	0.000123	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—DHFR—bone cancer	1.18e-05	0.000122	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—JUN—bone cancer	1.17e-05	0.000122	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MMP9—bone cancer	1.14e-05	0.000118	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GNA11—bone cancer	1.1e-05	0.000114	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CYP3A4—bone cancer	1.1e-05	0.000114	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CYP3A4—bone cancer	1.09e-05	0.000113	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GSTP1—bone cancer	1.07e-05	0.000112	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ENO2—bone cancer	1.07e-05	0.000111	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NT5C3A—bone cancer	1.06e-05	0.000111	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GSTP1—bone cancer	1.03e-05	0.000107	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ENO2—bone cancer	1.02e-05	0.000107	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ENO2—bone cancer	1e-05	0.000104	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1e-05	0.000104	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ENO2—bone cancer	1e-05	0.000104	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CYP3A4—bone cancer	9.99e-06	0.000104	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—bone cancer	9.9e-06	0.000103	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—DHFR—bone cancer	9.89e-06	0.000103	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—DHFR—bone cancer	9.51e-06	9.88e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ENO2—bone cancer	9.46e-06	9.84e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GSTP1—bone cancer	9.4e-06	9.77e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KIT—bone cancer	9.34e-06	9.71e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GSTP1—bone cancer	9.32e-06	9.68e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—DHFR—bone cancer	9.31e-06	9.68e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—DHFR—bone cancer	9.29e-06	9.66e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GNA11—bone cancer	9.25e-06	9.61e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—bone cancer	9.19e-06	9.55e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTGS2—bone cancer	9.17e-06	9.54e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GNA11—bone cancer	8.89e-06	9.24e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—DHFR—bone cancer	8.78e-06	9.13e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—BRAF—bone cancer	8.78e-06	9.12e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GNA11—bone cancer	8.7e-06	9.05e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GNA11—bone cancer	8.69e-06	9.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ENO2—bone cancer	8.68e-06	9.02e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFBR2—bone cancer	8.56e-06	8.9e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GSTP1—bone cancer	8.54e-06	8.88e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.43e-06	8.76e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTGS2—bone cancer	8.39e-06	8.72e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CYP3A4—bone cancer	8.38e-06	8.71e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTGS2—bone cancer	8.31e-06	8.63e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GNA11—bone cancer	8.21e-06	8.53e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CYP3A4—bone cancer	8.06e-06	8.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—DHFR—bone cancer	8.05e-06	8.37e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CYP3A4—bone cancer	7.89e-06	8.2e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP3A4—bone cancer	7.87e-06	8.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ENO2—bone cancer	7.75e-06	8.05e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—bone cancer	7.72e-06	8.02e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ENO2—bone cancer	7.56e-06	7.86e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GNA11—bone cancer	7.52e-06	7.82e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CYP3A4—bone cancer	7.44e-06	7.73e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.4e-06	7.69e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—bone cancer	7.37e-06	7.66e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MDM2—bone cancer	7.35e-06	7.64e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—DHFR—bone cancer	7.19e-06	7.47e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GSTP1—bone cancer	7.17e-06	7.45e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ENO2—bone cancer	7.12e-06	7.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ENO2—bone cancer	7.06e-06	7.34e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—DHFR—bone cancer	7.01e-06	7.29e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GSTP1—bone cancer	6.89e-06	7.16e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP3A4—bone cancer	6.82e-06	7.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.79e-06	7.05e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GSTP1—bone cancer	6.75e-06	7.01e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GSTP1—bone cancer	6.73e-06	7e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GNA11—bone cancer	6.72e-06	6.98e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—DHFR—bone cancer	6.61e-06	6.87e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GNA11—bone cancer	6.55e-06	6.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—DHFR—bone cancer	6.55e-06	6.81e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—JUN—bone cancer	6.39e-06	6.64e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GSTP1—bone cancer	6.36e-06	6.61e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MMP9—bone cancer	6.22e-06	6.46e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GNA11—bone cancer	6.18e-06	6.42e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—bone cancer	6.15e-06	6.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GNA11—bone cancer	6.12e-06	6.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP3A4—bone cancer	6.09e-06	6.33e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.06e-06	6.3e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP3A4—bone cancer	5.94e-06	6.18e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KIT—bone cancer	5.84e-06	6.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GSTP1—bone cancer	5.83e-06	6.06e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP3A4—bone cancer	5.6e-06	5.82e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—bone cancer	5.56e-06	5.78e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP3A4—bone cancer	5.55e-06	5.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.52e-06	5.74e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—BRAF—bone cancer	5.49e-06	5.71e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—bone cancer	5.35e-06	5.56e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTP1—bone cancer	5.21e-06	5.41e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTP1—bone cancer	5.08e-06	5.28e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—bone cancer	5.03e-06	5.22e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—bone cancer	4.87e-06	5.06e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—bone cancer	4.83e-06	5.02e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—bone cancer	4.79e-06	4.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—bone cancer	4.75e-06	4.93e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO2—bone cancer	4.66e-06	4.84e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—bone cancer	4.6e-06	4.78e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—bone cancer	4.42e-06	4.6e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—DHFR—bone cancer	4.32e-06	4.49e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—bone cancer	4.22e-06	4.39e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GNA11—bone cancer	4.04e-06	4.2e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—bone cancer	3.57e-06	3.71e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—bone cancer	3.5e-06	3.63e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—bone cancer	3.49e-06	3.63e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—bone cancer	3.3e-06	3.43e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—bone cancer	3.14e-06	3.27e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—bone cancer	3.13e-06	3.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—bone cancer	3.02e-06	3.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—bone cancer	2.7e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—bone cancer	2.63e-06	2.74e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—bone cancer	2.48e-06	2.58e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—bone cancer	2.46e-06	2.56e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—bone cancer	1.62e-06	1.69e-05	CbGpPWpGaD
